Mecamylamine reversal by nicotine and by a partial α7 nicotinic acetylcholine receptor agonist (GTS-21) in rabbits tested with delay eyeblink classical conditioning
- 14 August 2003
- journal article
- research article
- Published by Elsevier in Behavioural Brain Research
- Vol. 143 (2) , 159-167
- https://doi.org/10.1016/s0166-4328(03)00039-1
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Ventral hippocampal α7 nicotinic receptor blockade and chronic nicotine effects on memory performance in the radial-arm mazePharmacology Biochemistry and Behavior, 2001
- Nicotinic receptor stimulation protects neurons against β‐amyloid toxicityAnnals of Neurology, 1997
- Eyeblink Classical Conditioning in Alzheimer's Disease and Cerebrovascular DementiaNeurobiology of Aging, 1996
- Nicotine Enhancement of Fast Excitatory Synaptic Transmission in CNS by Presynaptic ReceptorsScience, 1995
- Evaluation of Cognition‐enhancing Drugs: Utility of the Model System of Eyeblink Classical ConditioningCNS Drug Reviews, 1995
- Disruption of classical conditioning in patients with Alzheimer's diseaseNeurobiology of Aging, 1991
- A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homo-oligomeric channel blocked by α-BTXNeuron, 1990
- Eyeblink conditioning discriminates Alzheimerʼs patients from non-demented agedNeuroReport, 1990
- Alzheimer's Disease: A Disorder of Cortical Cholinergic InnervationScience, 1983
- The septohippocampal cholinergic system and classical conditioning of the rabbit's nictitating membrane response.Journal of Comparative and Physiological Psychology, 1981